GO:0048687 positive regulation of sprouting of injured axon: Axon Regeneration Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048687 describes any process that activates, maintains or increases the rate of sprouting of an injured axon, a key biological process in neural repair.
• Axon sprouting after injury involves extensive cytoskeletal remodeling, including changes in tubulin and neurofilament synthesis and phosphorylation of MAP1B.
• Astrocytes and other non-neuronal cells can promote or inhibit axon growth in the injured central nervous system through secreted factors and extracellular matrix molecules.
• Chemokines such as CXCL10 and myelin-associated inhibitors like Nogo receptor ligands modulate the extent of axon sprouting after spinal cord injury.
• Studying positive regulation of sprouting of injured axon requires models of peripheral and central nervous system injury combined with genetic manipulation and imaging.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in axon sprouting and regeneration.
Description
Positive regulation of sprouting of injured axon (GO:0048687) is a biological process that encompasses any mechanism which activates, maintains, or increases the rate of new axon growth from injured neurons. This process is central to neural repair after trauma, stroke, or neurodegenerative damage, and it determines the extent to which damaged neural circuits can reconnect. Understanding its molecular drivers is essential for developing therapies that enhance regeneration in the peripheral and central nervous systems. Axon sprouting after injury is not a single event but a coordinated program involving cytoskeletal reorganization, growth cone dynamics, and interactions with glial and extracellular matrix components. For example, after spinal cord injury, sprouting axons show increased phosphorylated MAP1B, a marker of structural remodeling, while astrocytes can either promote or restrict growth depending on the context. Similarly, neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting, highlighting the role of inflammatory mediators in this process. Because failed or excessive sprouting contributes to functional deficits and aberrant plasticity, researchers need robust models to dissect the positive regulators of this process.
positive regulation of sprouting of injured axon At A Glance
| GO ID | GO:0048687 |
|---|---|
| GO term | positive regulation of sprouting of injured axon |
| Ontology | biological_process |
| Synonym | activation of sprouting of injured axon; stimulation of sprouting of injured axon; up regulation of sprouting of injured axon; up-regulation of sprouting of injured axon; upregulation of sprouting of injured axon |
| Major function | Enhances the rate or extent of new axon growth from injured neurons |
| Related process | Axon regeneration, neural plasticity, cytoskeletal remodeling |
| Cellular context | Neurons, growth cones, glial cells, extracellular matrix |
| Research relevance | Target for neural repair therapies after spinal cord injury, peripheral nerve injury, and neurodegeneration |
What Is GO:0048687?
According to the Gene Ontology, GO:0048687 is defined as any process that activates, maintains or increases the rate of sprouting of an injured axon. In other words, it covers the molecular and cellular events that positively regulate the formation of new axonal branches or extensions from a damaged axon, as opposed to the initial injury response or negative regulatory mechanisms.
Why Is positive regulation of sprouting of injured axon Important in Cell Biology?
Positive regulation of sprouting of injured axon is critically important because it determines whether damaged neurons can re-establish functional connections, and its manipulation holds therapeutic potential for spinal cord injury, peripheral nerve damage, and neurodegenerative conditions.
• Enhances functional recovery after spinal cord injury by promoting new axonal branches.
• Supports peripheral nerve regeneration and sensory-motor recovery.
• Involves cytoskeletal remodeling that can be targeted pharmacologically.
• Modulated by glial cells and extracellular matrix molecules such as neurocan and Nogo receptor ligands.
• Influenced by neurotrophins like BDNF through truncated trkB receptors on non-neuronal cells.
• Chemokine signaling, e.g., CXCL10, can suppress sprouting, so its neutralization enhances regeneration.
• Astrocytes can promote axon growth in the injured CNS under certain conditions.
• Dysregulation of sprouting may contribute to neuropathic pain or aberrant plasticity.
• Provides a readout for testing gene function in vivo using injury models.
• Key for developing CRISPR-based gene therapies for neural repair.
What Happens During positive regulation of sprouting of injured axon?
Injury sensing and growth cone activation
In simple terms: After an axon is injured, the damaged tip must sense the damage and switch into a growth mode.
Following axon injury, the neuron undergoes a series of changes that can lead to sprouting. This includes the activation of growth-associated programs and the formation of a new growth cone. Studies using phosphorylated MAP1B as a marker have revealed extensive structural remodeling of the injured spinal cord, with sprouting axons showing dynamic cytoskeletal changes. The capacity of astrocytes to promote axon growth in the injured mammalian central nervous system further highlights the role of the cellular environment in this early phase.
Cytoskeletal reorganization and tubulin synthesis
In simple terms: The neuron rebuilds its internal skeleton to extend a new branch.
Axon sprouting requires coordinated changes in cytoskeletal protein synthesis. After axon injury, there are changes in the synthesis of tubulin and neurofilament proteins that support the growth of new axonal processes. This cytoskeletal remodeling is essential for the structural plasticity observed during sprouting, as demonstrated by the presence of phosphorylated MAP1B in sprouting axons after spinal cord injury.
Modulation by glial and extracellular matrix factors
In simple terms: Support cells and the matrix around the axon can either encourage or block new growth.
The extracellular environment strongly influences whether sprouting occurs. Reactive astrocytes can express chondroitin sulfate proteoglycans such as neurocan after entorhinal cortex lesion, which may affect plasticity. Conversely, astrocytes can also promote axon growth in the injured CNS under certain conditions. The balance between growth-promoting and growth-inhibitory molecules determines the net positive regulation of sprouting.
Chemokine and neurotrophin signaling
In simple terms: Chemical signals from immune cells and growth factors can turn sprouting up or down.
Inflammatory mediators and neurotrophins modulate sprouting. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury, indicating that CXCL10 normally restrains sprouting. BDNF signaling through truncated trkB receptors on non-neuronal cells can inhibit neurite outgrowth in vitro, suggesting that non-neuronal trkB isoforms may limit positive regulation. These signaling pathways are potential targets for enhancing sprouting.
Myelin-associated inhibition and its relief
In simple terms: Myelin contains proteins that block sprouting, and overcoming them can boost regeneration.
Myelin-associated inhibitors such as Nogo receptor ligands limit axon sprouting. A soluble Nogo receptor can differentially affect plasticity of spinally projecting axons, indicating that blocking this inhibitory pathway can promote sprouting. Thus, positive regulation of sprouting can be achieved by relieving inhibition as well as by directly activating growth programs.
Key Genes Involved in GO:0048687 positive regulation of sprouting of injured axon
The following genes and proteins have been implicated in the positive regulation of sprouting of injured axon, based on experimental evidence from injury models and in vitro studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAP1B | Microtubule-associated protein involved in cytoskeletal remodeling | Phosphorylated MAP1B marks sprouting axons after spinal cord injury |
| CXCL10 | Chemokine that can suppress axon sprouting | Neutralization increases sprouting and reduces apoptosis after spinal cord injury |
| BDNF | Neurotrophin that promotes neurite outgrowth | Truncated trkB receptors on non-neuronal cells inhibit BDNF-induced outgrowth |
| NTRK2 (TrkB) | BDNF receptor; truncated forms may inhibit outgrowth | Soluble or truncated trkB modulates BDNF effects on sprouting |
| NGFR (p75) | Nogo receptor co-receptor | Soluble Nogo receptor affects plasticity of spinally projecting axons |
| RTN4R (Nogo receptor) | Mediates inhibition by myelin proteins | Soluble Nogo receptor differentially affects axon plasticity |
| NCAN (neurocan) | Chondroitin sulfate proteoglycan in reactive astrocytes | Induced after entorhinal cortex lesion; may influence plasticity |
| GFAP | Astrocyte marker; reactive astrocytes can promote or inhibit growth | Astrocytes capacity to promote axon growth in injured CNS |
| TUBB3 | Neuronal beta-tubulin; cytoskeletal component | Changes in tubulin synthesis after axon injury support regeneration |
| NEFL | Neurofilament light chain; cytoskeletal component | Altered synthesis after axon injury and during regeneration |
| NEFM | Neurofilament medium chain; cytoskeletal component | Cytoskeletal changes during axon regeneration |
| NEFH | Neurofilament heavy chain; cytoskeletal component | Cytoskeletal changes during axon regeneration |
| STAT3 | Transcription factor in reactive astrocytes | May regulate astrocyte-mediated promotion of axon growth |
| SOCS3 | Negative regulator of STAT3 | Modulates astrocyte reactivity and axon regeneration |
| PTEN | Phosphatase that limits axon growth | Deletion enhances regeneration in CNS neurons |
| mTOR | Kinase that promotes protein synthesis for growth | Central regulator of axon regeneration capacity |
| RhoA | Small GTPase mediating growth inhibition | Target for promoting sprouting after injury |
| ROCK | RhoA effector kinase | Inhibition can enhance axon sprouting |
How Is positive regulation of sprouting of injured axon Regulated?
The positive regulation of sprouting of injured axon is controlled by a balance of growth-promoting and growth-inhibitory signals. Key regulatory nodes include the mTOR pathway, which promotes protein synthesis required for growth, and the STAT3/SOCS3 axis in reactive astrocytes, which modulates the supportive capacity of glia. Chemokine signaling, such as CXCL10, can suppress sprouting, and its neutralization enhances regeneration. Neurotrophin signaling through full-length versus truncated trkB receptors also determines the outcome of BDNF stimulation. Additionally, myelin-associated inhibitors acting through the Nogo receptor and RhoA/ROCK pathway constrain sprouting, and their blockade can relieve inhibition. Extracellular matrix molecules like neurocan may further tune the response.
positive regulation of sprouting of injured axon and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL10 | Spinal cord injury; inflammation | CXCL10 knockout mice with spinal cord injury; sprouting assays |
| RTN4R | Spinal cord injury; myelin inhibition | Soluble Nogo receptor treatment in spinal cord injury models |
| NCAN | Entorhinal cortex lesion; glial scar | Neurocan knockout or overexpression in entorhinal cortex lesion |
| BDNF/NTRK2 | Neurite outgrowth; neurotrophin signaling | Truncated trkB overexpression in co-cultures |
| MAP1B | Spinal cord injury; cytoskeletal remodeling | MAP1B phosphorylation mutants in spinal cord injury |
Spinal cord injury
After spinal cord injury, axon sprouting is often limited by inhibitory molecules and inflammatory mediators. Neutralization of CXCL10 increases axon sprouting and reduces apoptosis, suggesting that targeting this chemokine could improve outcomes. Phosphorylated MAP1B is observed in sprouting axons and degenerating neurons, serving as a marker of structural remodeling. Soluble Nogo receptor can modulate plasticity of spinally projecting axons, indicating that blocking myelin inhibition may promote repair.
Peripheral nerve injury
Peripheral nerve injury triggers a robust regenerative response that includes axon sprouting. Neural plasticity after peripheral nerve injury involves changes in cytoskeletal protein synthesis and growth-associated programs. Understanding positive regulation in this context can inform strategies to enhance functional recovery.
Neurodegenerative conditions and glial scarring
In conditions where chronic glial scarring occurs, reactive astrocytes and chondroitin sulfate proteoglycans such as neurocan can limit axon sprouting. However, astrocytes also have the capacity to promote axon growth in the injured CNS, and harnessing this potential is a therapeutic goal. Modulating the balance between inhibitory and promoting factors is key.
From positive regulation of sprouting of injured axon-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote axon sprouting after spinal cord injury? | Knockout mouse with spinal cord injury and anterograde tracing |
| Does a point mutation in gene Y affect growth cone dynamics? | Point-mutation knock-in in primary neurons |
| Can overexpression of gene Z enhance sprouting? | AAV-mediated overexpression in injured CNS |
| What is the role of a specific isoform? | Tagged knock-in for isoform-specific labeling |
| How does glial-derived factor affect sprouting? | Conditional knockout in astrocytes |
| Can CRISPR activation of gene A boost regeneration? | dCas9-VP64 activation in vivo |
How to Study the positive regulation of sprouting of injured axon Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Anterograde tracing | Axon sprouting and regeneration | Spinal cord injury models |
| Phospho-MAP1B immunohistochemistry | Cytoskeletal remodeling in sprouting axons | Spinal cord injury tissue |
| Neurite outgrowth assay | Rate and extent of neurite extension | Primary neurons with gene manipulation |
| RNA-seq | Transcriptional changes after injury | Injured neurons or glia |
| Proteomics | Protein synthesis and modifications | Axon regeneration studies |
| CRISPR knockout | Loss-of-function effects on sprouting | In vitro and in vivo injury models |
| CRISPR activation (dCas9-VP64) | Gain-of-function effects on sprouting | Enhancing regeneration |
| Co-culture with glia | Non-cell-autonomous effects | Astrocyte-neuron interactions |
In vivo injury models and tracing
Studying positive regulation of sprouting of injured axon often requires animal models of spinal cord injury or peripheral nerve injury combined with anterograde or retrograde tracing to visualize sprouting axons. Phosphorylated MAP1B immunohistochemistry can mark sprouting axons and degenerating neurons. Behavioral tests assess functional recovery.
Primary neuron culture and growth cone assays
In vitro models using primary neurons or explants allow precise manipulation of candidate genes and measurement of neurite outgrowth. Co-cultures with non-neuronal cells expressing truncated trkB can test the inhibitory role of these receptors on BDNF-induced outgrowth. Time-lapse imaging of growth cones provides dynamic readouts.
Transcriptomics and proteomics
RNA sequencing and proteomics of injured neurons or surrounding glia can identify changes in cytoskeletal protein synthesis and signaling pathways. Changes in tubulin and neurofilament synthesis after axon injury have been documented. These approaches can reveal novel positive regulators.
Genetic manipulation and CRISPR screens
CRISPR knockout, knock-in, and overexpression enable causal testing of genes in sprouting. For example, neutralizing CXCL10 via genetic deletion or antibody blockade increases sprouting. Soluble Nogo receptor can be overexpressed to relieve inhibition. Pooled CRISPR screens in primary neurons can identify novel regulators of neurite outgrowth.
How CRISPR Can Be Used to Study GO:0048687 positive regulation of sprouting of injured axon
Knockout
CRISPR knockout of candidate genes such as CXCL10 can be used to test whether removing an inhibitory factor enhances axon sprouting after spinal cord injury. Knockout of negative regulators like PTEN or SOCS3 in neurons or glia can also reveal their roles in positive regulation.
Point Mutation
Point mutations can be introduced to mimic phosphorylation or dephosphorylation sites on cytoskeletal proteins like MAP1B, allowing precise testing of their role in sprouting. Similarly, mutations in signaling domains of receptors such as trkB can dissect isoform-specific functions.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci enables visualization of protein localization and dynamics in sprouting axons. Tagged knock-in of neurofilament or tubulin genes can reveal cytoskeletal dynamics. Knock-in of reporter genes under the control of sprouting-associated promoters can monitor pathway activation.
Overexpression
Overexpression of growth-promoting genes such as BDNF or soluble Nogo receptor via viral vectors can enhance sprouting. For example, soluble Nogo receptor overexpression differentially affects plasticity of spinally projecting axons. Overexpression of constitutively active mTOR or STAT3 can boost regeneration.
How EDITGENE Supports positive regulation of sprouting of injured axon Research
Researchers studying positive regulation of sprouting of injured axon-related genes often need to determine whether a candidate gene is causally involved in enhancing or inhibiting axon sprouting. This requires precise genetic models that can be deployed in injury paradigms, from knockout mice to conditional knock-ins and overexpression systems. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of sprouting of injured axon research.
Frequently Asked Questions About positive regulation of sprouting of injured axon
What is GO:0048687 positive regulation of sprouting of injured axon?
GO:0048687 is a Gene Ontology biological process term defined as any process that activates, maintains or increases the rate of sprouting of an injured axon.
What genes are involved in positive regulation of sprouting of injured axon?
Genes such as MAP1B, CXCL10, BDNF, NTRK2, RTN4R, NCAN, and cytoskeletal proteins like tubulin and neurofilaments have been implicated.
How is axon sprouting after injury studied?
Researchers use in vivo injury models with tracing, primary neuron cultures, and genetic manipulation including CRISPR to measure sprouting.
What role do astrocytes play in axon sprouting?
Astrocytes can promote axon growth in the injured CNS, but they can also express inhibitory molecules like neurocan depending on context.
Can CRISPR be used to enhance axon sprouting?
Yes, CRISPR knockout of inhibitory genes like CXCL10 or overexpression of growth-promoting genes can enhance sprouting in preclinical models.
What is the role of CXCL10 in axon sprouting?
CXCL10 is a chemokine that suppresses axon sprouting; its neutralization increases sprouting and reduces apoptosis after spinal cord injury.
How does BDNF affect sprouting of injured axons?
BDNF can promote neurite outgrowth, but truncated trkB receptors on non-neuronal cells can inhibit this effect.
What is the significance of phosphorylated MAP1B in sprouting?
Phosphorylated MAP1B is a marker of cytoskeletal remodeling in sprouting axons after spinal cord injury.
What are the challenges in promoting axon sprouting in the CNS?
Inhibitory molecules in myelin and glial scar, such as Nogo and chondroitin sulfate proteoglycans, limit sprouting and require targeted interventions.
How can EDITGENE help with axon sprouting research?
EDITGENE provides CRISPR knockout, knock-in, overexpression models, library screening, and bioinformatics to study genes involved in positive regulation of sprouting.
Conclusion
Positive regulation of sprouting of injured axon (GO:0048687) is a fundamental biological process that governs neural repair after injury. It integrates cytoskeletal remodeling, glial interactions, and signaling pathways that can be targeted to enhance regeneration. Understanding the genes and mechanisms involved is essential for developing therapies for spinal cord injury, peripheral nerve damage, and neurodegenerative conditions. With advanced CRISPR tools and injury models, researchers can now dissect these pathways with unprecedented precision.
References
- 1. Hemati-Gourabi M et al.. 2022. Capacity of astrocytes to promote axon growth in the injured mammalian central nervous system.. Front Neurosci 16:955598 PMID: 36203815
- 2. Glaser J et al.. 2006. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury.. J Neurosci Res 84(4):724-34 PMID: 16862543
- 3. Navarro X et al.. 2007. Neural plasticity after peripheral nerve injury and regeneration.. Prog Neurobiol 82(4):163-201 PMID: 17643733
- 4. Soares S et al.. 2007. Extensive structural remodeling of the injured spinal cord revealed by phosphorylated MAP1B in sprouting axons and degenerating neurons.. Eur J Neurosci 26(6):1446-61 PMID: 17880387
- 5. Bisby MA et al.. 1992. Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration.. Mol Neurobiol 6(2-3):107-23 PMID: 1476674
- 6. Fryer RH et al.. 1997. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.. Exp Neurol 148(2):616-27 PMID: 9417837
- 7. MacDermid VE et al.. 2004. A soluble Nogo receptor differentially affects plasticity of spinally projecting axons.. Eur J Neurosci 20(10):2567-79 PMID: 15548200
- 8. Haas CA et al.. 1999. Entorhinal cortex lesion in adult rats induces the expression of the neuronal chondroitin sulfate proteoglycan neurocan in reactive astrocytes.. J Neurosci 19(22):9953-63 PMID: 10559403
